ELAB — Elevai Labs Balance Sheet
0.000.00%
- $9.44m
- $8.50m
- $1.71m
Annual balance sheet for Elevai Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.013 | 0.412 | 1.15 | 3.33 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0 | 0.002 | 0.013 | 0.036 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.017 | 0.637 | 1.55 | 4.92 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0 | 0.03 | 0.33 | 0.26 |
Other Long Term Assets | ||||
Total Assets | 0.017 | 0.666 | 1.89 | 5.19 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.041 | 0.216 | 0.588 | 1.3 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.041 | 0.216 | 0.761 | 1.36 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.024 | 0.451 | 1.13 | 3.83 |
Total Liabilities & Shareholders' Equity | 0.017 | 0.666 | 1.89 | 5.19 |
Total Common Shares Outstanding |